UBS lowers Rithm Capital stock price target on valuation update

Eli Lilly (LLY +0.76%) was second to market with a GLP-1 weight-loss drug, losing out to Novo Nordisk (NVO 2.31%). However, Eli Lilly’s Mounjaro and Zepbound produce stronger weight-loss results than Novo Nordisk’s Wegovy, and they quickly took the lead. Now, many on Wall Street see Eli Lilly as a GLP-1 stock, which it is….

en English Economics Jul 27, 2026 Dambisa Moyo Companies have poured billions of dollars into AI in anticipation of transformative productivity gains and cost savings, but the returns have yet to justify those investments. Rising costs, intellectual-property risks, and mounting cybersecurity…

The storage maker’s June-quarter results come in ahead of Wall Street’s expectations, and the stock rallies after hours

BOE Bailey is back on the wires saying: Disinflation is proceeding slowly. Labour market is weakening gradually. Markets are pricing and potential interest rate increases While a low hire rate, economy is contributing to unemployment The BOE Rate unchanged today with a vote of 6-3. In his press conference, Bank of England Governor Andrew Bailey…

Despite a series of major negative shocks, some of them unprecedented, the US economy continues to grow in line with its estimated long-run potential. Yet given obvious and mounting risks, from debt-financed speculation to geopolitical tensions, the appearance of resilience should not be confused with the real thing.

The GBP/USD pair edges lower during the Asian session on Thursday and retreats further from its highest level since May 11, touched the previous day. Spot prices slip below the 1.3600 mark in the last hour, though the fundamental backdrop seems tilted in favor of bulls and backs the case for the emergence of some…